Data are from 538 patients who received the telemonitoring intervention and transmitted at least 3 weight values during the 180 days of the study.
Data include only 1 weight transmission per patient per day.
Types of days during the study period for 16 patients who had a total adherence of 47% to 53%.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Haynes SC, Tancredi DJ, Tong K, et al. Association of Adherence to Weight Telemonitoring With Health Care Use and Death: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2020;3(7):e2010174. doi:10.1001/jamanetworkopen.2020.10174
¿El cumplimiento de la telemonitorización del peso está asociado con el uso de la atención médica y la muerte de los pacientes con insuficiencia cardíaca?
Este análisis secundario post hoc de un ensayo clínico aleatorizado que incluyó a 538 participantes determinó que el aumento del cumplimiento de la telemonitorización del peso en una semana determinada se asociaba con una disminución significativa del riesgo de hospitalización posterior o de muerte en la semana siguiente. La adhesión no se asoció con las visitas al departamento de emergencias.
La adhesión a la telemonitorización puede estar asociada con el riesgo de hospitalización y de muerte de los pacientes con insuficiencia cardíaca.
Adherence to telemonitoring may be associated with heart failure exacerbation but is not included in telemonitoring algorithms.
To assess whether telemonitoring adherence is associated with a patient’s risk of hospitalization, emergency department visit, or death.
Design, Setting, and Participants
This post hoc secondary analysis of the Better Effectiveness After Transition–Heart Failure randomized clinical trial included patients from 6 academic medical centers in California who were eligible if they were hospitalized for decompensated heart failure and excluded if they were discharged to a skilled nursing facility, were expected to improve because of a medical procedure, or did not have the cognitive or physical ability to participate. The trial compared a telemonitoring intervention with usual care for patients with heart failure after hospital discharge from October 12, 2011, to September 30, 2013. Data analysis was performed from November 8, 2016, to May 10, 2019.
The intervention group (n = 722) received heart failure education, telephone check-ins, and a wireless telemonitoring system that allowed the patient to transmit weight, blood pressure, heart rate, and selected symptoms. The control group (n = 715) received usual care. Patients were followed up for 180 days after discharge.
Main Outcomes and Measures
The main outcome was within-person risk of hospitalization, emergency department visit, or death by week during the study period. Poisson regression was used to determine the within-person association of adherence to daily weighing with the risk of experiencing these events in the following week.
Among the 538 participants (mean [SD] age, 70.9 [14.1] years; 287 [53.8%] male; 269 [50.7%] white) in the present analysis, adherence was lowest during the first week after enrollment but steadily increased, peaking between days 26 and 60 at 69%, or 371 transmissions. Adherence to weight telemonitoring was associated with events in the following week; an increase in adherence by 1 day was associated with a 19% decrease in the rate of death in the following week (incidence rate ratio, 0.81; 95% CI, 0.73-0.90) and an 11% decrease in the rate of hospitalization (incidence rate ratio, 0.89; 95% CI, 0.86-0.91). Adherence in the previous week was not associated with reduced rates of emergency department visits (incidence rate ratio, 0.95; 95% CI, 0.90-1.02).
Conclusions and Relevance
In this study, lower adherence to weight telemonitoring in a given week was associated with an increased risk of subsequent hospitalization or death in the following week. It is unlikely that this is a result of the telemonitoring intervention; rather, adherence may be an important factor associated with a patient’s health status.
Heart failure affects millions of Americans and is projected to increase in prevalence.1,2 Management of heart failure is complex, often requiring substantial lifestyle changes, including dietary restrictions, medication management, monitoring of symptoms, and other measures. As a result, many patients have difficulty with self-management, which may contribute to high rates of subsequent hospitalization. Heart failure is the most common cause of subsequent hospitalization for adults older than 65 years; more than half of patients are readmitted within the first 6 months after discharge.2,3
Telemonitoring interventions seek to help patients with heart failure more effectively manage and avoid exacerbation and its consequences, including subsequent hospitalization and death. Telemonitoring interventions for heart failure typically involve transmission of daily weight values and may also include monitoring of other signs and symptoms, scheduled check-ins with nurses or physicians, or educational components. Evidence for telemonitoring is mixed. A 2015 systematic review4 reported moderate evidence for lowering all-cause hospitalizations. A 2018 systematic review5 found that telemonitoring in patients with heart failure significantly reduced hospitalization rates at 6 and 12 months.
In a previous study on telemonitoring, Zhang et al6 found that patients experienced a lapse in adherence before hospitalization and suggested that this lapse may be an important factor associated with patient outcomes. However, details on this lapse were not provided. In fact, to our knowledge, no studies to date have examined the association between adherence to telemonitoring and patient outcomes. The objective of this study was to describe patterns of adherence to a weight telemonitoring intervention and assess whether a change in adherence was associated with a patient’s risk of hospitalization, emergency department (ED) visit, or death.
This was a post hoc secondary analysis of the Better Effectiveness After Transition–Heart Failure (BEAT-HF) trial (NCT01360203), which compared rates of subsequent hospitalization among patients receiving a telemonitoring intervention with those among patients who received usual care after hospitalization for decompensated heart failure. The telemonitoring intervention included heart failure education, monthly telephone check-ins by study nurses, and a wireless telemonitoring system that allowed the patient to transmit daily weight, blood pressure, heart rate, and selected symptoms. Patients were enrolled during a hospitalization for decompensated heart failure. Enrollment hospitalizations could have been the first hospitalization for heart failure or a readmission for previously diagnosed heart failure. Participants were followed up for 180 days after discharge from the enrollment hospitalization. Participants completed surveys on demographic information, social support, health literacy, heart failure–related self-management, depression, and other comorbidities at baseline, 7 days, 30 days, and 180 days. All participants were at least 50 years of age. The BEAT-HF study was approved by the University of California, Los Angeles institutional review board; all participants provided written informed consent. This secondary analysis was covered under the original institutional review board approval because it did not involve additional contact or data collection from or about participants. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
Enrollment took place at 6 academic medical centers in California from October 12, 2011, to September 30, 2013.7,8 Patients were excluded from the trial if they were discharged to a skilled nursing facility or other contact-intensive environment, if they were expected to improve because of a medical procedure (such as a heart transplant), or if they did not have the cognitive or physical ability to participate in the study activities. In total, 1437 patients were randomized to the telemonitoring intervention (n = 722) or to usual care (n = 715). The primary outcome of this study was experiencing a hospitalization, ED visit, or death in a given week. The complete study protocol can be found in the Supplement. We restricted the current investigation to patients in the telemonitoring intervention who transmitted at least 3 weight values during the study period.
We focused solely on adherence to the weight telemonitoring component of the BEAT-HF intervention. To explore patterns of adherence, we removed from the denominator days during which the patient was hospitalized, in the ED, or dead. We then examined transmissions by study day, day of the week, and calendar month to describe overall adherence over time.
To examine the association of adherence with subsequent hospitalization, ED visits, and death, we created 1-week intervals beginning the day after discharge from the index hospitalization. These intervals were defined as including an event (hospitalization, ED visit, or death) or being event free. If a participant died during a hospitalization, this event was counted as a death. For a hospitalization that spanned multiple 1-week intervals, only the first 1-week interval was included in the analysis. During the remainder of the hospitalization, the patient was temporarily considered not at risk; thus, those intervals were excluded from the analysis. Intervals after the discharge from the hospitalization were included because the participant was considered to have resumed being at risk for the events of interest. We calculated adherence in event-free weeks as a count of adherent days, which had values of 0 (if no transmissions occurred during the week) through 7 (if weights were transmitted daily). We fit a conditional fixed-effects Poisson regression model to determine the within-person association of adherence with the risk of experiencing an event in the following week. We controlled for the number of previous events (hospitalizations or ED visits) experienced during the study and the number of study months that had elapsed. Number of months in the study was calculated by dividing the number of days in the study by 30.5. The natural logarithm of the interval was included as an offset term. We repeated the analysis restricting to deaths only, hospitalizations only, and ED visits only. We report 2-tailed tests of significance at the P < .05 level. Data analysis was performed from November 8, 2016, to May 10, 2019. All statistical analyses were performed using Stata software, version 14.2 (StataCorp).
A total of 538 patients (mean [SD] age, 70.9 [14.1] years; 287 [53.8%] male; 269 [50.7%] white) transmitted at least 3 weight values using the wireless scale and were included in this study. Of the 538 participants, 351 (65.2%) did not have a college degree. Of those who reported income, 169 (39.4%) reported earning less than $25 000 per year. A total of 49 participants (9.1%) died during the 180-day study period. A total of 257 participants (47.8%) were subsequently hospitalized at least once during the study period, and 95 (17.7%) had at least 1 ED visit. Table 1 gives the demographic and health characteristics of participants.
We identified a total of 88 751 person-days as potentially adherent days during which participants were alive, were not hospitalized, and did not visit the ED. Weight transmissions occurred on 47 300 days (53.3%). Figure 1 shows adherence to weight transmissions by study day. Adherence was lowest during the first week after enrollment in the study but steadily increased, peaking between days 26 and 60 and then gradually tapering off so that by the end of the study, mean adherence was still higher than in the first 30 days. On the peak days, 371 patients (69.0%) transmitted a weight value. Participants were less likely to submit a weight value on a weekend day compared with a weekday (69 142 [54.3%] vs 27 698 [50.1%], P < .001). Adherence also differed by month, with lower adherence in the winter months; December had the lowest adherence of any month (6821 [46.5%]), whereas August had the highest (9722 [55.8%]). Figure 2 shows the total number of weight transmissions during the study period; although many participants only transmitted weight values several times, participants also commonly transmitted weight values for more than 80% of study days. Figure 3 shows a subset of 16 patients with similar total adherence (between 47% and 53%) but with markedly different patterns of adherence.
Table 2 gives the incidence rate ratios (IRRs) and 95% CIs for events, adjusted for adherence in the previous week, number of previous events, and days elapsed in the study. Adherence to weight telemonitoring was associated with events in the following week. An increase in adherence by 1 day was associated with a decreased rate of experiencing an event by a factor of 0.90 (95% CI, 0.87-0.92; P < .001). In other words, a 1-day increase in adherence during the prior week was associated with a 10% decrease in the rate of events. The association was strongest for deaths; a 1-day increase in adherence was associated with a 19% decrease in the rate of death in the following week (IRR, 0.81; 95% CI, 0.73-0.90; P < .001). A 1-day increase in adherence in the prior week was associated with an 11% decrease in the rate of hospitalization (IRR, 0.89; 95% CI, 0.86-0.91; P < .001). Adherence in the previous week was not associated with reduced rates of ED visits alone (IRR, 0.95; 95% CI, 0.90-1.02; P = .15). For all types of events, experiencing previous events was associated with an increased rate of events. In contrast, an increase in months elapsed in the study was associated with a decrease in risk of hospitalizations and ED visits.
Our study’s approach is unique in that we examine telemonitoring adherence as a dynamic measure. This approach is in contrast to previous studies8-14 that reported telemonitoring adherence solely as a percentage of study days during which the patient adhered to the intervention. The static nature of this measure is problematic and limits the usefulness of adherence as a predictor in modeling and an outcome in itself. Our examination of patient adherence revealed that adherence was not a static but rather a dynamic measure that often changed within patients over time and had a variety of patterns. As shown in Figure 3, the use of 50% as a cutoff point for adherence shows a subset of 16 patients with similar total adherence (47%-53%) but with markedly different patterns of adherence. The use of 50% as a cutoff point for adherence would miss these differences and has important implications for studying adherence. We believe that adherence should not be categorized as a percentage of possible days or actions but rather as a measure that changes over time. Future research on adherence patterns should explore the possibility of defining adherence phenotypes that describe the way in which people adhere to treatment or monitoring over time. Recent work by Ware et al15 has also addressed the importance of examining adherence over time.
Our results align with the results of other studies15,16 that indicate that adherence to telemonitoring decreases over time. However, we found that adherence was highest in the second month of the intervention, suggesting that there may be an adjustment period in the first several weeks before adherence peaks. This finding is in contrast to that of a previous study16 that reported that adherence was highest at the start of an intervention and decreased after the first several weeks or months. This finding may be in part attributable to posthospital syndrome, which describes increased physiological and psychological stress after a hospitalization.17 If patients struggled with poor health or were overwhelmed after the index hospitalization, they may have needed some time to adjust to the new demand of daily monitoring. Alternatively, patients may have encountered initial difficulty setting up the device. Intuitively, our findings indicate that adherence was lower around the winter holidays and on weekends. Because these times may also be when patients are less likely to adhere to other management strategies, such as salt and fluid restriction, implementers of telemonitoring should make a special effort to encourage adherence to telemonitoring during these times.
We found that lower adherence in a given week was associated with increased risk of experiencing a subsequent hospitalization or death in the following week. It is unlikely that this is a result of the actual telemonitoring intervention itself. Rather, this is likely an example of adherence bias or the healthy adherer effect, which refers to the idea that people who adhere to medications or health interventions are typically healthier and more health seeking than are those who do not. This phenomenon has been widely observed in the context of medication adherence.18-20 Although there is a paucity of literature on this effect in telemonitoring, it is plausible that adherence to weight telemonitoring may be associated with improved patient status. If patients stop adhering to telemonitoring, they may also be failing to adhere to medications or dietary restrictions, which may lead to a heart failure exacerbation. In addition, if patients are feeling weak or frail, this may inhibit adherence to weight telemonitoring and may be a sign of decompensating heart failure. These hypotheses are outside the scope of our study. Nevertheless, our findings have important implications for the design of telemonitoring systems; lack of adherence may suggest a more urgent need for intervention.
Several telemonitoring researchers6,21,22 have worked to develop algorithms for predicting subsequent hospital admissions using a variety of measures. A study by Koulaouzidis et al21 found that an algorithm using a combination of weight and blood pressure was effective for predicting readmission. However, the authors noted that their predictions were limited by low patient adherence to telemonitoring. Our study supports the suggestions by Zhang et al6 and Koulaouzidis et al21 that adherence may add value to these predictive models. Our review of the literature did not find any interventions that included adherence to telemonitoring as a factor associated with readmission. However, several previous studies23,24 have found medication adherence to be associated with subsequent hospitalization. Wu et al23 found that patients who reported that they had missed no doses of their medication in the past week had significantly lower rates of all-cause subsequent hospitalization and death. Another study24 found a similar decrease in the risk of subsequent hospitalization among patients with heart failure with improved medication adherence measured by a microelectronic monitoring device in the caps of medication containers. Further research examining the association between medication adherence and adherence to telemonitoring may provide additional insights into the use of these measures as potential predictors of patient outcomes.
This study has limitations. First, we did not take into account how often participants were contacted by study staff after a nonadherent period and what the outcomes of these calls were. It is possible that patients were contacted after a period of nonadherence and instructed to go to the hospital after speaking with the patient about their symptoms. However, it is unknown whether any readmissions could have been successfully avoided, and this explanation does not suffice to explain the association between adherence and subsequent death. Second, we did not have information on the length of stay for patients who were discharged to a skilled nursing facility after subsequent hospitalization. Skilled nursing facility stays may impede adherence to telemonitoring for various reasons, including access to the scale, connectivity problems, and prohibitive policies of the facility. Therefore, this impediment may have resulted in an underestimation of possible adherent days. Third, we were unable to account for days when patients experienced technical problems with the scales. Scale transmission error could have affected our results by underestimating adherent days. We believe that this error, if significant, could have diminished our effect size.
In this study, lower adherence in a given week was associated with an increased risk of subsequent hospitalization or death in the following week. It is unlikely that this is a result of the telemonitoring intervention; rather, adherence may be an important factor associated with a patient's health status. This study found an association between adherence and subsequent health care use and mortality. We believe that algorithms that alert nurses and physicians when values of weight or other measures are outside the reference range should be adapted to include alerts for changes in adherence to telemonitoring. Such algorithms may help to improve effectiveness of telemonitoring for heart failure. In the future, automated and implantable devices that do not require voluntary effort may be more effective for improving heart failure management.
Accepted for Publication: April 30, 2020.
Published: July 10, 2020. doi:10.1001/jamanetworkopen.2020.10174
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Haynes SC et al. JAMA Network Open.
Corresponding Author: Sarah C. Haynes, PhD, MPH, Center for Health and Technology, Department of Pediatrics, UC Davis Health, 4610 X St, Sacramento, CA 95817 (email@example.com).
Author Contributions: Dr Haynes had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Haynes, Tancredi, Tong, Ganiats, Evangelista, Black, Auerbach, Romano.
Acquisition, analysis, or interpretation of data: Haynes, Tancredi, Hoch, Ong, Ganiats, Evangelista, Romano.
Drafting of the manuscript: Haynes, Ganiats, Auerbach.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Haynes, Tancredi, Hoch.
Obtained funding: Ganiats, Evangelista, Romano.
Administrative, technical, or material support: Haynes, Ganiats.
Supervision: Tong, Black, Romano.
Conflict of Interest Disclosures: Dr Ong reported receiving grants from the Agency for Healthcare Research and Quality (AHRQ), the Robert Wood Johnson Foundation (RWJF), the National Heart, Lung, and Blood Institute (NHLBI), the National Center for Advancing Translational Sciences (NCATS), and the Sierra Health Foundation during the conduct of the study. Dr Ganiats reported receiving grants from University of California San Diego during the conduct of the study. Dr Romano reported receiving grants from AHRQ during the conduct of the study. No other disclosures were reported.
Funding/Support: The original BEAT-HF study was supported by grant R01HS019311 from the AHRQ (Dr Ong); grant RC2HL101811 from the NHLBI; grant UL1TR000124 from NCATS of the University of California, Los Angeles, Clinical and Translational Science Institute; grant 66336 from the RWJF (Dr Ong); the Sierra Health Foundation (Dr Ong); the University of California Center for Health Quality and Innovation (Dr Ong); and the participating institutions. No additional funding was obtained for this secondary analysis.
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: In addition to the authors of the current article, other members of the Better Effectiveness After Transition–Heart Failure (BEAT-HF) Research Group (in alphabetical order) are Bruce Davidson, PhD, MBA, Hassan Ghasemzadeh, PhD, Michael Gropper, MD, MPH, and Michelle Mourad, MD. The BEAT-HF project managers are Arjang Ahmadpour, BS, Wendy Davila, RN, Susanne Engel, MBA, Ronald Jacolbia, BS, Herman Lee, BS, Laura Linares, RN, Elizabeth Michel, RN, Meghan Soulsby Weyrich, MS, and Elizabeth Zellmer, BS. The BEAT-HF postdischarge intervention nurses are Lida Esbati-Mashayekhi, RN, Elisabeth Haddad, RN, Marian Haskins, RN, Tianne Larson, RN, and Kathryn Pratt, RN. The BEAT-HF enrollment nurses are Hendry Ansorie, RN, Kymberly Aoki, RN, Ruth Baron, RN, Eileen Brinker, RN, Maureen Carroll, RN, Annette Contasti, RN, Anne Fekete, RN, Vivian Guzman, RN, Linda Larsen, RN, Lisa Martinez, RN, Sharon Myers, RN, Melanee Schimmel, RN, Amanda Schnell-Heringer, RN, Arlene Taylor, RN, Tracy Tooley, RN, Geoffrey van den Brande, RN, and Evanthia Zaharias, RN. The BEAT-HF research staff includes John Billimek, PhD, Rocio Castaneda, BS, Ma Elloi Delos Reyes, BS, Dana Fine, BS, Tammy Lo, BS, Xoan Luu, BA, Socorro Ochoa, BA, Mayra Perez, BA, David Rincon, BA, Fidelia Sillas, BA, Visith Uy, BS, Esther Wang, BS, Haiyong Xu, PhD, Stella Yala, MD, and Tingjian Yan, PhD.
Meeting Presentation: These findings were presented in part at the Society of General Internal Medicine Annual Meeting; May 10, 2019; Washington, DC, and National Telehealth Research Symposium; September 12, 2019; Chicago, IL.
Additional Contributions: Eduard Poltavskiy, PhD, US Air Force, provided programming support, for which he did not receive compensation.
Create a personal account or sign in to: